Abstract:Background and objective: Cardiovascular imaging is an exponentially growing field with aspects ranging from image acquisition and analysis to disease characterization, and evaluation of therapy approaches.The transfer of innovative new technological and algorithmic solutions into clinical practice is still slow. In addition to the verification of solutions, their integration in the clinical processing workflow must be enabled for the assessment of clinical impact and risks. The goal of our software platform for cardiac image processing - CAIPI - is to support researchers from different specialties such as imaging physics, computer science, and medicine by a common extensible platform to address typical challenges and hurdles in interdisciplinary cardiovascular imaging research. It provides an integrated solution for method comparison, integrated analysis, and validation in the clinical context. The interface concept enables a combination with existing frameworks that address specific aspects of the pipeline, such as modeling (e.g., OpenCMISS, CARP) or image reconstruction (Gadgetron). Methods: In our platform, we developed a concept for import, integration, and management of cardiac image data. The integration approach considers the spatiotemporal properties of the beating heart through a specific data model. The solution is based on MeVisLab and provides functionalities for data retrieval and storage. Two types of plugins can be added. While ToolPlugins usually provide processing algorithms such as image correction and segmentation, AnalysisPlugins enable interactive data exploration and reporting. GUI integration concepts are presented for both plugin types. We developed domain-specific reporting and visualization tools (e.g., AHA segment model) to enable validation studies by clinical experts. The platform offers plugins for calculating and reporting quantitative parameters such as cardiac function, which can be used to, e.g., evaluate the effect of processing algorithms on clinical parameters. Export functionalities include quantitative measurements to Excel, image data to PACS, and STL models to modeling and simulation tools. Results: To demonstrate the applicability of this concept both for method development and clinical application, we present use cases representing different problems along the innovation chain in cardiac MR imaging. Validation of an image reconstruction method (MRI T1 mapping) Validation of an image correction method for real-time 2D-PC MRI Comparison of quantification methods for blood flow analysis Training and integration of machine learning solutions with expert annotations Clinical studies with new imaging techniques (flow measurements in the carotid arteries and peripheral veins as well as cerebral spinal fluid). Conclusion: The presented platform can be used in interdisciplinary teams, in which engineers or data scientists perform the method validation, followed by clinical research studies in patient collectives. The demonstrated use cases show how it enables the transfer of innovations through validation in the cardiovascular application context.

Building credibility of computational models in cardiovascular medicine through verification and validation

Integration of Different Cardiac Electrophysiological Models into a Single Simulation Pipeline

Computer modelling and artificial intelligence with big data for better diagnostics and therapy of cardiovascular disease

SILICOFCM platform, multiscale modeling of left ventricle from echocardiographic images and drug influence for cardiomyopathy disease

An extensible software platform for interdisciplinary cardiovascular imaging research

In-vitro Major Arterial Cardiovascular Simulator to generate Benchmark Data Sets for in-silico Model Validation

Cardiovascular disease models: A game changing paradigm in drug discovery and screening

The Current State of Realistic Heart Models for Disease Modelling and Cardiotoxicity

Scientific and regulatory evaluation of mechanistic in silico drug and disease models in drug development: Building model credibility

Simulation-based Inference for Cardiovascular Models

Computational Modeling on Drugs Effects for Left Ventricle in Cardiomyopathy Disease

Advancing clinical translation of cardiac biomechanics models: a comprehensive review, applications and future pathways

Guidelines for mechanistic modeling and analysis in cardiovascular research

The ‘Digital Twin’ to enable the vision of precision cardiology

Initial clinical validation of a hybrid in silico—in vitro cardiorespiratory simulator for comprehensive testing of mechanical circulatory support systems

Computational modeling of cardiac electrophysiology and arrhythmogenesis: toward clinical translation

A Unique Cardiac Electrophysiological 3D Model

Creation and application of virtual patient cohorts of heart models

CRIMSON: An open-source software framework for cardiovascular integrated modelling and simulation

The virtual assay software for human in silico drug trials to augment drug cardiac testing

Toward trustworthy medical device in silico clinical trials: a hierarchical framework for establishing credibility and strategies for overcoming key challenges